Product NDC: | 0187-2206 |
Proprietary Name: | CeraVe |
Non Proprietary Name: | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone |
Active Ingredient(s): | 4.23; 21.15; 7.05; 14.1; 8.46 g/141g; g/141g; g/141g; g/141g; g/141g & nbsp; Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SPRAY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0187-2206 |
Labeler Name: | Valeant Pharmaceuticals North America LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20121128 |
Package NDC: | 0187-2206-01 |
Package Description: | 141 g in 1 TUBE (0187-2206-01) |
NDC Code | 0187-2206-01 |
Proprietary Name | CeraVe |
Package Description | 141 g in 1 TUBE (0187-2206-01) |
Product NDC | 0187-2206 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone |
Dosage Form Name | SPRAY |
Route Name | TOPICAL |
Start Marketing Date | 20121128 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Valeant Pharmaceuticals North America LLC |
Substance Name | AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE |
Strength Number | 4.23; 21.15; 7.05; 14.1; 8.46 |
Strength Unit | g/141g; g/141g; g/141g; g/141g; g/141g |
Pharmaceutical Classes |